Key Events 2021

Constructing CLINUVEL’s Future: the Next Phase

The past year witnessed multiple key events in CLINUVEL’s commercial operations, research and development program, financial performance, communications and analyst coverage, and advanced strategy which collectively, are forming the future of the Group.

Since the end of the financial year, and in addition to the 2021 financial results and dividend announced in August 2021, we have achieved further progress in the R&D program.

Continued Strong Financial Performance

5th consecutive Annual profit delivered
4th consecutive Annual dividend declared
5th consecutive Annual positive cashflow
Graphic - Radio tower

Wider Engagement with the Investor Community

Jeffries Australia Initiates Research Coverage of CUV

First Virtual AGM

Operations Update Webinar I

Wilsons Initiates Research Coverage of CUV

Strategic Update I

Strategic Update II

Chair’s Interview Series

Growth of CLINUVEL

Four divisions announced

Enabling Patients to Access Treatment

Enabling patient access to treatment
Expanding R&D